Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 686

1.

Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML, Morra E, Pangalis GA, San Miguel JF, Branagan AR, Dimopoulos MA.

Semin Oncol. 2003 Apr;30(2):110-5. Review.

PMID:
12720118
2.

Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Kyle RA, Treon SP, Alexanian R, Barlogie B, Björkholm M, Dhodapkar M, Lister TA, Merlini G, Morel P, Stone M, Branagan AR, Leblond V.

Semin Oncol. 2003 Apr;30(2):116-20. Review.

PMID:
12720119
3.

Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Weber D, Treon SP, Emmanouilides C, Branagan AR, Byrd JC, Bladé J, Kimby E.

Semin Oncol. 2003 Apr;30(2):127-31. Review.

PMID:
12720121
4.

Developing diagnostic criteria in Waldenstrom's macroglobulinemia.

Owen RG.

Semin Oncol. 2003 Apr;30(2):196-200.

PMID:
12720135
5.

Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Gertz MA, Anagnostopoulos A, Anderson K, Branagan AR, Coleman M, Frankel SR, Giralt S, Levine T, Munshi N, Pestronk A, Rajkumar V, Treon SP.

Semin Oncol. 2003 Apr;30(2):121-6. Review.

PMID:
12720120
6.

Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.

Vitolo U, Ferreri AJ, Montoto S.

Crit Rev Oncol Hematol. 2008 Aug;67(2):172-85. doi: 10.1016/j.critrevonc.2008.03.008. Epub 2008 May 21. Review.

PMID:
18499469
7.

Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?

Gobbi PG, Baldini L, Broglia C, Goldaniga M, Comelli M, Morel P, Morra E, Cortelazzo S, Bettini R, Merlini G.

Clin Cancer Res. 2005 Mar 1;11(5):1786-90.

8.

Differential diagnosis of Waldenstrom's macroglobulinemia from other low-grade B-cell lymphoproliferative disorders.

Pangalis GA, Kyrtsonis MC, Kontopidou FN, Vassilakopoulos TP, Siakantaris MP, Dimopoulou MN, Kittas C, Angelopoulou MK.

Semin Oncol. 2003 Apr;30(2):201-5.

PMID:
12720136
9.

Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity?

Berger F, Traverse-Glehen A, Felman P, Callet-Bauchu E, Baseggio L, Gazzo S, Thieblemont C, Ffrench M, Magaud JP, Salles G, Coiffer B.

Clin Lymphoma. 2005 Mar;5(4):220-4. Review.

PMID:
15794852
10.

Factors predicting transformation of asymptomatic IgM monoclonal gammopathy.

Greco A, Tedeschi A, Varettoni M, Nichelatti M, Paris L, Ricci F, Vismara E, Morra E.

Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):77-9. doi: 10.3816/CLML.2011.n.012.

PMID:
21454196
11.

Differential diagnosis of Waldenstrom's macroglobulinemia and other B-cell disorders.

Pangalis GA, Kyrtsonis MC, Kontopidou FN, Siakantaris MP, Dimopoulou MN, Vassilakopoulos TP, Tzenou T, Kokoris S, Dimitriadou E, Kalpadakis C, Tsalimalma K, Tsaftaridis P, Panayiotidis P, Angelopoulou MK.

Clin Lymphoma. 2005 Mar;5(4):235-40.

PMID:
15794855
12.

Differential diagnosis of IgM MGUS and WM according to B-lymphoid infiltration by morphology and flow cytometry.

Ocio EM, del Carpio D, Caballero Á, Alonso J, Paiva B, Pesoa R, Villaescusa T, López-Anglada L, Vidriales B, García-Sanz R.

Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):93-5. doi: 10.3816/CLML.2011.n.017.

PMID:
21454201
13.

Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia.

Basu D, Pathak D, Shyambabu C, Koner BC, Swaminathan RP.

Indian J Pathol Microbiol. 2004 Oct;47(4):515-7.

PMID:
16295380
14.

Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system.

Baldini L, Goldaniga M, Guffanti A, Broglia C, Cortelazzo S, Rossi A, Morra E, Colombi M, Callea V, Pogliani E, Ilariucci F, Luminari S, Morel P, Merlini G, Gobbi P.

J Clin Oncol. 2005 Jul 20;23(21):4662-8.

PMID:
16034042
15.

Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.

Martín-Jiménez P, García-Sanz R, Balanzategui A, Alcoceba M, Ocio E, Sanchez ML, González M, San Miguel J.

Haematologica. 2007 May;92(5):635-42.

16.

IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).

Kyle RA, Dispenzieri A, Kumar S, Larson D, Therneau T, Rajkumar SV.

Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):74-6. doi: 10.3816/CLML.2011.n.011.

PMID:
21454195
17.
18.

Prognosis and treatment of Waldenström's macroglobulinemia.

Louw VJ, Webb MJ.

Transfus Apher Sci. 2010 Apr;42(2):193-7. doi: 10.1016/j.transci.2010.01.017. Epub 2010 Feb 8. Review.

PMID:
20117052
19.

Immunophenotypic analysis of Waldenstrom's macroglobulinemia.

San Miguel JF, Vidriales MB, Ocio E, Mateo G, Sánchez-Guijo F, Sánchez ML, Escribano L, Bárez A, Moro MJ, Hernández J, Aguilera C, Cuello R, García-Frade J, López R, Portero J, Orfao A.

Semin Oncol. 2003 Apr;30(2):187-95. Erratum in: Semin Oncol. 2002 Jun;15(2):427.

PMID:
12720134
20.

Immunoglobulin heavy chain sequence analysis in Waldenstrom's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance.

Rollett RA, Wilkinson EJ, Gonzalez D, Fenton JA, Short MA, Evans PA, Rawstron AC, Owen RG.

Clin Lymphoma Myeloma. 2006 Jul;7(1):70-2.

PMID:
16879773

Supplemental Content

Support Center